Marijuana products with high levels of THC increase the risk of psychosis and schizophrenia, according to a new evidence review, but their impact on anxiety and depression remains unclear.
Health News is provided as a service to Viallon Drug Co. site users by HealthDay. Viallon Drug Co. nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.